Vaccine Advisory Panel Rejects Mercury
This is a U.S. news story, published by CNBC, that relates primarily to Arcadia news.
U.S. news
For more U.S. news, you can click here:
more U.S. newsNews about vaccine development
For more vaccine development news, you can click here:
more vaccine development newsCNBC news
For more news from CNBC, you can click here:
more news from CNBCAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
thimerosal flu vaccines. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest flu vaccines news, dose flu vaccines news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
vaccine skepticismCNBC
•Health
Health
Healthy Returns: What to know about a CDC vaccine panel's votes against a mercury preservative in flu shots
86% Informative
A panel of vaccine advisors has voted against a mercury-containing shot ingredient that the anti-vaccine movement has long targeted.
There is no evidence of harm from thimerosal, which has been linked to developmental disabilities.
The Centers for Disease Control and Prevention still needs to sign off on that recommendation.
The recommendation would affect roughly 4% to 5% of U.S. flu vaccine supply.
Arcadia and Nordic Capital did not disclose the terms of the acquisition.
The deal is expected to close in the second half of the year .
Arcadia last raised outside funding in 2023 , when it announced $125 million in financing.
Nordic Capital's acquisition serves as an exit for earlier investors, Arcadia said.
VR Score
89
Informative language
89
Neutral language
66
Article tone
formal
Language
English
Language complexity
62
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
4
Affiliate links
no affiliate links